Search Browse Earnings

LianBio — SlamSEC

LianBio

OTC:LIANY

Pharmaceutical Preparations·PRINCETON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Stone Adam Leo

CFO

Gu Ehong

Revenue

—

Adj. EBITDA

-$195.0M

FY 2022

Net Income

-$196.3M

FY 2022

EPS (Diluted)

-$5.71

FY 2022

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$228.2M

FY 2022

Total Debt

—

Net Cash

$228.2M

Enterprise Value

—

Debt / EBITDA

1.2x

FY 2022

EV / EBITDA

—

Employees

—